(R)-2-(4-isobutylphenyl)propionylmethanesulfonamide,
2-(4-isobutylphenyl)propionylmethanesulfonamide,
reparixin,
repertaxin,
reparixin,
repertaxin,
266359-83-5,
UNII-U604E1NB3K,
DF 1681Y,
CHEMBL191413,
U604E1NB3K,
(R)-2-(4-isobutylphenyl)-N-(methylsulfonyl)propanamide,
Reparixin [USAN:INN],
(2R)-2-(4-(2-Methylpropyl)phenyl)-N-methylsulfonylpropanamide,
(2R)-2-[4-(2-methylpropyl)phenyl]-N-methylsulfonylpropanamide,
2-(4-isobutylphenyl)propionylmethanesulfonamide,
reparixin-repertaxin,
Reparixin (Repertaxin),
Reparixin (USAN/INN),
DSSTox_CID_26509,
DSSTox_RID_81678,
DSSTox_GSID_46509,
GTPL8498,
SCHEMBL1884299,
ZINC8717,
DTXSID6046509,
BCP10635,
DF-1681Y,
EX-A2461,
Tox21_112272,
BDBM50169045,
MFCD18633292,
CS-1379,
DB12614,
DF-1681,
SB17154,
Benzeneacetamide, alpha-methyl-4-(2-methylpropyl)-N-(methylsulfonyl)-, (alphaR)-,
HY-15251,
CAS-266359-83-5,
A12383,
D08984,
W-5776,
N-[(R)-2-(4-Isobutyl-phenyl)-propionyl]-methanesulfonamide,
Benzeneacetamide, alpha-methyl-4-(2-methylpropyl)-N-(methylsulfonyl)- (alphaR)-,
Reparixin [INN],
RAPARIXIN,
Reparixin (INN/USAN),
D06IDV,
D0LJ1B,
CID9838712,
NCGC00165968-01,
(R)-2-(4-isobutylphenyl)propionylmethanesulfonamide,
C490707,
266359-93-7,